"???Studies have shown that the early use of long-acting injectables can prevent a person with schizophrenia from experiencing a relapse,???5 said Ole Chrintz, SVP International Markets & Europe, Lundbeck. ???Efficacy is important, but a treatment for a chronic condition such as schizophrenia also needs to be well tolerated so patients will stay on it over the long-term." . . . .